Increased susceptibility to diseases, including cancer are associated with mutations in the NF-κB signaling pathway [42,49,96,97], while spontaneous mutations in the upstream activators and individual subunits of NF-κB are rare [96], they are more common in diseases of immunodeficiency [98,99]. This evidence concerns the gene NFKB1 and cancer.